These results suggest bortezomib administration overcomes IL-12 and IL-15 deficiency by increasing the expression of effector molecules and, thus, aids in reducing tumor pulmonary metastasis in 4T1HA-bearing mice. The gene discussed is IL15; the disease is neoplasm.